Exactmer is delighted to have been awarded the Startup Pitch and Partner award in the ‘Emerging’ category, at BioVaria 2022.
Exactmer’s winning pitch on the development of our proprietary Nanostar Sieving technology for oligonucleotide synthesis was chosen by a jury of leading investors, in a showcase of 13 hand-picked start ups from across Europe.
BioVaria is Europe’s leading showcasing event for life-science technologies, targeting technology scouts, business developers and investors, and bringing together Europe’s leading tech transfer professionals, innovators from academia and representatives of the global biotech and pharma industry.
This year’s event was held in Munich in May, bringing together over 230 life-science innovators to the two-day event, with more than 60 licensable innovations presented by leading players from all over Europe, from therapeutic and diagnostic approaches to platform technologies.
Read the full feature here.